You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 3, 2024

TOTECT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Totect, and when can generic versions of Totect launch?

Totect is a drug marketed by Clinigen and is included in one NDA.

The generic ingredient in TOTECT is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.

Summary for TOTECT
Drug patent expirations by year for TOTECT
Drug Prices for TOTECT

See drug prices for TOTECT

Recent Clinical Trials for TOTECT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 2
Children's Oncology GroupPhase 3
EsPhALL network I-BFM Study GroupPhase 3

See all TOTECT clinical trials

US Patents and Regulatory Information for TOTECT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen TOTECT dexrazoxane hydrochloride INJECTABLE;INJECTION 022025-001 Sep 6, 2007 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TOTECT

See the table below for patents covering TOTECT around the world.

Country Patent Number Title Estimated Expiration
Denmark 1162981 ⤷  Try a Trial
Australia 3272600 ⤷  Try a Trial
Portugal 1162981 ⤷  Try a Trial
European Patent Office 1459752 ⤷  Try a Trial
Germany 60010241 ⤷  Try a Trial
Russian Federation 2252761 ЛЕЧЕНИЕ СЛУЧАЙНОЙ ТРАНССУДАЦИИ АНТРАЦИКЛИНОВ (THERAPY OF SPORADIC TRANSUDATION OF ANTHRACYCLINES) ⤷  Try a Trial
Norway 20014433 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.